A detailed history of Naples Global Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Naples Global Advisors, LLC holds 10,700 shares of NEO stock, worth $151,726. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,700
Previous 10,700 -0.0%
Holding current value
$151,726
Previous $148,000 6.08%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021

BUY
$41.56 - $59.88 $236,892 - $341,316
5,700 Added 114.0%
10,700 $516,000
Q4 2020

Feb 08, 2021

BUY
$36.08 - $56.47 $180,400 - $282,350
5,000 New
5,000 $269,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.78B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Naples Global Advisors, LLC Portfolio

Follow Naples Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Naples Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Naples Global Advisors, LLC with notifications on news.